✦ LIBER ✦

A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer

✍ Scribed by Lee, J-L; Kang, Y-K; Kang, H J; Lee, K-H; Zang, D Y; Ryoo, B-Y; Kim, J G; Park, S R; Kang, W K; Shin, D B

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A multi-center phase II study of S-1 plu

✍ Jae Jin Lee; Si-Young Kim; Hyun-Cheol Chung; Kyung-Hee Lee; Hong-Suk Song; Won-K 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 355 KB

A phase II study of weekly carboplatin a

✍ Sandro Pignata; Enrico Breda; Giovanni Scambia; Carmela Pisano; Vittorina Zagone 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 208 KB

Docetaxel/gemcitabine or cisplatin/gemci

✍ D. Binder; H. Schweisfurth; C. Grah; C. Schäper; B. Temmesfeld-Wollbrück; G. Sie 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 340 KB

A phase II study of weekly docetaxel and

✍ Li, C-P; Chen, J-S; Chen, L-T; Yen, C-J; Lee, K-D; Su, W-P; Lin, P-C; Lu, C-H; T 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 286 KB